60.00
Schlusskurs vom Vortag:
$59.34
Offen:
$58.91
24-Stunden-Volumen:
80,763
Relative Volume:
0.15
Marktkapitalisierung:
$1.71B
Einnahmen:
$86.93M
Nettoeinkommen (Verlust:
$-1.48M
KGV:
-846.27
EPS:
-0.0709
Netto-Cashflow:
$431.00K
1W Leistung:
-3.78%
1M Leistung:
+33.68%
6M Leistung:
+257.01%
1J Leistung:
+234.01%
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Firmenname
Eton Pharmaceuticals Inc
Sektor
Telefon
(847) 787-7361
Adresse
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ETON
Eton Pharmaceuticals Inc
|
59.91 | 1.70B | 86.93M | -1.48M | 431.00K | -0.0709 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.27 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.75 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.155 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
73.45 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
497.09 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-23 | Bestätigt | H.C. Wainwright | Buy |
| 2025-01-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-01-06 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-05-06 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-01-04 | Bestätigt | H.C. Wainwright | Buy |
| 2019-09-20 | Eingeleitet | B. Riley FBR | Buy |
| 2019-06-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Eton Pharmaceuticals (ETON) Heads To Wells Fargo Conference As Fair Value Debate Stays Open - simplywall.st
118,249 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Bank of New York Mellon Corp - MarketBeat
(ETON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
ETON stock holds firm after latest quarter shows steady growth - AD HOC NEWS
Sigma Planning Corp Takes Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M - Benzinga
Hsbc Holdings PLC Invests $1.53 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals Director Paul V. Maier Executes Stock Options and Sells Shares on August 28, 2026 - Kalkine Media
Eton Pharmaceuticals (ETON) director unloads 50K shares after option exercise - Stock Titan
34,027 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Jefferies Financial Group Inc. - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Deutsche Bank AG Purchases Shares of 26,522 Eton Pharmaceuticals, Inc. $ETON - MarketBeat
BlackRock Inc. Invests $68.63 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Navellier & Associates Inc. Makes New Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals, Inc. $ETON Stock Holdings Increased by Bank of America Corp DE - MarketBeat
1,175,951 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Nantahala Capital Management LLC - MarketBeat
Cannell Capital LLC Acquires New Stake in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Director Sells $2,953,500.00 in Stock - MarketBeat
Eton Pharmaceuticals (NASDAQ: ETON) insider sells 50K shares - Stock Titan
Bank of Nova Scotia Acquires New Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Shares Down 4.4%Here's Why - MarketBeat
Eton leaders will hold one-on-one meetings at Wells Fargo’s Boston event - stocktitan.net
Pillsbury Lake Capital LLC Invests $14.02 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Panoramic Capital LLC Takes $7.54 Million Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton's Galzin TM And False Ad Suit Survives Dismissal Bid - Law360
Eton Pharmaceuticals Can Proceed With ‘Gluzin’ Supplement Suit - Bloomberg Law News
Eton Pharmaceuticals (NASDAQ:ETON) Rating Increased to Hold at Zacks Research - MarketBeat
Insider Unloading: David Krempa Sells Options, Realizes $1.43M - Benzinga
Eton Pharmaceuticals Inc (NASDAQ: ETON) Share Price, ETON Stock News, ETON Share Price & Updates - Kalkine
Eton Pharmaceuticals stock hits all-time high at 64.29 USD By Investing.com - Investing.com India
Eton Pharmaceuticals stock hits all-time high at 64.29 USD - Investing.com
Eton Pharmaceuticals (ETON) Returns To Profit As Valuation Debate Gets Harder To Ignore - Sahm
Eton Pharmaceuticals Inc (ETON) Stock Up 5.9% but GF Value Says Overvalued -- GF Score: 58/100 - GuruFocus
SEAN BRYNJELSEN Executes Sell Order: Offloads $6.09M In Eton Pharmaceuticals Stock - Benzinga
Eton Pharmaceuticals CEO Sean Brynjelsen Executes Four Stock Sales Over Two Days - Kalkine Media
Eton Pharmaceuticals CEO Sean Brynjelsen sells $6.08m in stock By Investing.com - Investing.com India
Eton Pharmaceuticals CEO Sean Brynjelsen sells $6.08m in stock - Investing.com
Eton Pharmaceuticals (NASDAQ:ETON) Reaches New 1-Year HighWhat's Next? - MarketBeat
Forecast: Analysts Think Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Business Prospects Have Improved Drastically - simplywall.st
Upgrade: Analysts Just Made A Notable Increase To Their Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Forecasts - 富途牛牛
Danka Radosavljevic Net Worth (2026) - GuruFocus
Biotech Stocks At 52-Week HighsETON +44%, DXCM, ORKA, CON, ATAI - RTTNews
This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day - Stocktwits
Eton Pharmaceuticals Stock Soars After Massive Q2 Beat And Guidance Hike - timothysykes.com
Responsive Playbooks and the ETON Inflection - Stock Traders Daily
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket - Sahm
Eton Pharmaceuticals Stock Soars After Huge Q2 Beat And Target Hikes - StocksToTrade
Eton Pharmaceuticals Soars After Blowout Q2 And Guidance Hike - timothysykes.com
Eton Pharmaceuticals Soars After Massive Q2 Beat And Guidance Hike - timothysykes.com
Eton Pharmaceuticals Soars As Q2 Beat Triggers Aggressive Target Hikes - StocksToTrade
Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):